JP2007507527A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007507527A5 JP2007507527A5 JP2006534125A JP2006534125A JP2007507527A5 JP 2007507527 A5 JP2007507527 A5 JP 2007507527A5 JP 2006534125 A JP2006534125 A JP 2006534125A JP 2006534125 A JP2006534125 A JP 2006534125A JP 2007507527 A5 JP2007507527 A5 JP 2007507527A5
- Authority
- JP
- Japan
- Prior art keywords
- biologically active
- solvent
- composition
- aqueous solution
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 13
- 239000000203 mixture Substances 0.000 claims 11
- 239000002904 solvent Substances 0.000 claims 7
- 239000007864 aqueous solution Substances 0.000 claims 6
- 239000002245 particle Substances 0.000 claims 6
- 239000013543 active substance Substances 0.000 claims 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 125000001931 aliphatic group Chemical group 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 229920001515 polyalkylene glycol Polymers 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 229920003169 water-soluble polymer Polymers 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000002265 Human Growth Hormone Human genes 0.000 claims 1
- 108010000521 Human Growth Hormone Proteins 0.000 claims 1
- 239000000854 Human Growth Hormone Substances 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims 1
- 239000004952 Polyamide Substances 0.000 claims 1
- 229920002732 Polyanhydride Polymers 0.000 claims 1
- 229920001710 Polyorthoester Polymers 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical group CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims 1
- 125000005907 alkyl ester group Chemical group 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 150000001261 hydroxy acids Chemical class 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims 1
- 239000002745 poly(ortho ester) Substances 0.000 claims 1
- 229920001281 polyalkylene Polymers 0.000 claims 1
- 229920002647 polyamide Polymers 0.000 claims 1
- 229920000515 polycarbonate Polymers 0.000 claims 1
- 239000004417 polycarbonate Substances 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50741303P | 2003-09-30 | 2003-09-30 | |
| PCT/US2004/032271 WO2005032511A2 (en) | 2003-09-30 | 2004-09-30 | Nanoparticulate therapeutic biologically active agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007507527A JP2007507527A (ja) | 2007-03-29 |
| JP2007507527A5 true JP2007507527A5 (enExample) | 2007-11-29 |
Family
ID=34421621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006534125A Pending JP2007507527A (ja) | 2003-09-30 | 2004-09-30 | 生物学的に活性なナノ粒子治療用因子 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050181059A1 (enExample) |
| EP (1) | EP1675571A2 (enExample) |
| JP (1) | JP2007507527A (enExample) |
| AU (1) | AU2004277419B2 (enExample) |
| CA (1) | CA2540771A1 (enExample) |
| WO (1) | WO2005032511A2 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050186183A1 (en) * | 2003-12-08 | 2005-08-25 | Deangelo Joseph | Stabilized products, processes and devices for preparing same |
| US8420122B2 (en) | 2006-04-28 | 2013-04-16 | Merck Sharp & Dohme Corp. | Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same |
| US20080193518A1 (en) * | 2006-04-28 | 2008-08-14 | Schering Corporation | Process for the precipitation and isolation of 6,6-Dimethyl-3-Aza Bicyclo [3.1.0] Hexane-Amide compounds by controlled precipitation and pharmaceutical formulations containing same |
| US20090311295A1 (en) * | 2006-05-12 | 2009-12-17 | Edith Mathiowitz | Particles with high uniform loading of nanoparticles and methods of preparation thereof |
| WO2008144365A2 (en) * | 2007-05-17 | 2008-11-27 | Novartis Ag | Method for making dry powder compositions containing ds-rna based on supercritical fluid technology |
| US9504274B2 (en) | 2009-01-27 | 2016-11-29 | Frito-Lay North America, Inc. | Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom |
| US20100189845A1 (en) * | 2009-01-27 | 2010-07-29 | Frito-Lay North America Inc. | Flavor Encapsulation and Method Thereof |
| US8685458B2 (en) | 2009-03-05 | 2014-04-01 | Bend Research, Inc. | Pharmaceutical compositions of dextran polymer derivatives |
| US20100310726A1 (en) | 2009-06-05 | 2010-12-09 | Kraft Foods Global Brands Llc | Novel Preparation of an Enteric Release System |
| US9968564B2 (en) * | 2009-06-05 | 2018-05-15 | Intercontinental Great Brands Llc | Delivery of functional compounds |
| US8859003B2 (en) * | 2009-06-05 | 2014-10-14 | Intercontinental Great Brands Llc | Preparation of an enteric release system |
| US20100307542A1 (en) * | 2009-06-05 | 2010-12-09 | Kraft Foods Global Brands Llc | Method of Reducing Surface Oil on Encapsulated Material |
| EP2461818B1 (en) | 2009-08-03 | 2018-10-17 | Incube Labs, Llc | Swallowable capsule and method for stimulating incretin production within the intestinal tract |
| US8759284B2 (en) | 2009-12-24 | 2014-06-24 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8815294B2 (en) | 2010-09-03 | 2014-08-26 | Bend Research, Inc. | Pharmaceutical compositions of dextran polymer derivatives and a carrier material |
| JP5808413B2 (ja) * | 2010-09-30 | 2015-11-10 | エボニック コーポレイションＥｖｏｎｉｋ Ｃｏｒｐｏｒａｔｉｏｎ | 微粒子から残留有機溶剤を除去する方法 |
| RU2013119810A (ru) * | 2010-09-30 | 2014-11-10 | Эвоник Корпорейшн | Эмульсионный способ получения микрочастиц с низким содержанием остаточного растворителя |
| US20120148675A1 (en) * | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| US8980822B2 (en) | 2010-12-23 | 2015-03-17 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8846040B2 (en) | 2010-12-23 | 2014-09-30 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10639272B2 (en) | 2010-12-23 | 2020-05-05 | Rani Therapeutics, Llc | Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9283179B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9861683B2 (en) | 2010-12-23 | 2018-01-09 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8969293B2 (en) | 2010-12-23 | 2015-03-03 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9284367B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9629799B2 (en) | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402807B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9060938B2 (en) | 2011-05-10 | 2015-06-23 | Bend Research, Inc. | Pharmaceutical compositions of active agents and cationic dextran polymer derivatives |
| TWI425979B (zh) * | 2011-10-28 | 2014-02-11 | Univ Ming Chi Technology | 次微米級微粒的製備方法 |
| US8859005B2 (en) | 2012-12-03 | 2014-10-14 | Intercontinental Great Brands Llc | Enteric delivery of functional ingredients suitable for hot comestible applications |
| CA2913923A1 (en) * | 2013-05-31 | 2014-12-04 | Newleaf Symbiotics, Inc. | Bacterial fermentation methods and compositions |
| CN106794156B (zh) * | 2014-07-08 | 2021-03-09 | 美药星制药股份有限公司 | 微粒化胰岛素、微粒化胰岛素类似物及其制备方法 |
| US10322168B2 (en) | 2016-01-07 | 2019-06-18 | Amphastar Pharmaceuticals, Inc. | High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same |
| US11491114B2 (en) * | 2016-10-12 | 2022-11-08 | Curioralrx, Llc | Formulations for enteric delivery of therapeutic agents |
| US20210290733A1 (en) * | 2018-07-16 | 2021-09-23 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Injectable micronized human insulin |
| WO2024011218A1 (en) * | 2022-07-08 | 2024-01-11 | Brown University | Polymeric nanoparticles for long acting delivery of a peptide and methods of making and using thereof |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3460631A (en) * | 1966-11-14 | 1969-08-12 | Friesen Ind Inc | High clearance wheel mounted spring-tooth harrow |
| US3483951A (en) * | 1968-12-06 | 1969-12-16 | Wisconsin Alumni Res Found | Self-optimizing vibration dampers |
| US3828860A (en) * | 1973-02-28 | 1974-08-13 | Kewanne Machinery & Conveyor C | Agricultural implement with foldable wings |
| US4107288A (en) * | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| US4151273A (en) * | 1974-10-31 | 1979-04-24 | The Regents Of The University Of California | Increasing the absorption rate of insoluble drugs |
| US4050522A (en) * | 1976-03-29 | 1977-09-27 | J. I. Case Company | Multi-section harrow assembly |
| CA1145607A (en) * | 1979-06-19 | 1983-05-03 | Malcolm F. Ferber | Agricultural implement carriage system |
| IT1130924B (it) * | 1980-03-06 | 1986-06-18 | Secifarma Spa | Procedimento per la preparazione di spironolattone micronizzato |
| US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
| DE3744329A1 (de) * | 1987-12-28 | 1989-07-06 | Schwarz Pharma Gmbh | Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung |
| ATE146359T1 (de) * | 1992-01-21 | 1997-01-15 | Stanford Res Inst Int | Verbessertes verfahren zur herstellung von mikronisierter polypeptidarzneimitteln |
| US5639441A (en) * | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
| IS1796B (is) * | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
| GB9313642D0 (en) * | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
| DE4329446A1 (de) * | 1993-09-01 | 1995-03-02 | Basf Ag | Verfahren zur Herstellung von feinteiligen Farb- oder Wirkstoffzubereitungen |
| FR2722984B1 (fr) * | 1994-07-26 | 1996-10-18 | Effik Lab | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees |
| SE9403846D0 (sv) * | 1994-11-09 | 1994-11-09 | Univ Ohio State Res Found | Small particle formation |
| US5747002A (en) * | 1995-04-05 | 1998-05-05 | Genentech, Inc. | Preparation of sodium chloride aerosol formulations |
| US6143211A (en) * | 1995-07-21 | 2000-11-07 | Brown University Foundation | Process for preparing microparticles through phase inversion phenomena |
| US5874029A (en) * | 1996-10-09 | 1999-02-23 | The University Of Kansas | Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent |
| US5833891A (en) * | 1996-10-09 | 1998-11-10 | The University Of Kansas | Methods for a particle precipitation and coating using near-critical and supercritical antisolvents |
| US5817343A (en) * | 1996-05-14 | 1998-10-06 | Alkermes, Inc. | Method for fabricating polymer-based controlled-release devices |
| US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US5855913A (en) * | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US5800834A (en) * | 1996-06-10 | 1998-09-01 | Spireas; Spiridon | Liquisolid systems and methods of preparing same |
| AUPR197000A0 (en) * | 2000-12-08 | 2001-01-11 | Unisearch Limited | Synthesis of small particles |
| IL156682A0 (en) * | 2000-12-29 | 2004-01-04 | Pbl Biomedical Lab | Controlled release systems for polymers |
| GB0102075D0 (en) * | 2001-01-26 | 2001-03-14 | Astrazeneca Ab | Process |
| SG126676A1 (en) * | 2001-05-09 | 2007-01-30 | Nanomaterials Tech Pte Ltd | Process for the controlled production of organic particles |
| WO2003049701A2 (en) * | 2001-12-10 | 2003-06-19 | Spherics, Inc. | Methods and products useful in the formation and isolation of microparticles |
-
2004
- 2004-09-30 AU AU2004277419A patent/AU2004277419B2/en not_active Ceased
- 2004-09-30 JP JP2006534125A patent/JP2007507527A/ja active Pending
- 2004-09-30 CA CA002540771A patent/CA2540771A1/en not_active Abandoned
- 2004-09-30 US US10/954,423 patent/US20050181059A1/en not_active Abandoned
- 2004-09-30 WO PCT/US2004/032271 patent/WO2005032511A2/en not_active Ceased
- 2004-09-30 EP EP04785328A patent/EP1675571A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007507527A5 (enExample) | ||
| CN1507357A (zh) | 提高生物活性分子传递的方法和组合物 | |
| Islam et al. | Recent advances in chitosan-based nanoparticulate pulmonary drug delivery | |
| ES2718612T3 (es) | Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual | |
| CA2127805C (en) | Composition for nasal administration | |
| CN101466353B (zh) | 延长释放活性成分的药物制剂及其应用，尤其是治疗应用 | |
| CN1205248C (zh) | 能溶解在有机溶剂中的生物可降解的聚环氧烷－聚(对－二噁烷酮)嵌段共聚物及含该共聚物的药物供送组合物 | |
| ES2444951T5 (es) | Películas uniformes para una forma farmacéutica de disolución rápida que incorpora composiciones de enmascaramiento del sabor | |
| JP5491119B2 (ja) | 薬物含有微粒子を含む医薬組成物およびその製造方法 | |
| JP2004509914A5 (enExample) | ||
| K Garg et al. | Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers | |
| KR20230093248A (ko) | 전 세포 성분이 로딩된 표적 수송 시스템 및 이의 용도 | |
| EP1864653A2 (en) | Nanoparticles of chitosan and polyethyleneglycol as a system for the administration of biologically-active molecules | |
| CN101678112B (zh) | 用于递送治疗剂的方法和组合物 | |
| CN102264351A (zh) | 包含水溶性差的药物的聚合胶束组合物的制备方法 | |
| JP2011037876A5 (enExample) | ||
| JP2008517878A5 (enExample) | ||
| CN103316352B (zh) | 氧化石墨烯纳米药物载体、抗肿瘤药物及其制备方法 | |
| CN101693111A (zh) | 一种提高聚乳酸类微球对水溶性蛋白包封率的方法 | |
| CN1252130C (zh) | 亲水性聚合物与丹参酮类药物的结合物以及包含该结合物的药物组合物 | |
| CN1261101C (zh) | 壳聚糖甘草酸纳米粒子及其制备方法 | |
| CN1878800A (zh) | pH敏感性聚合物及其制备方法 | |
| JP2005524421A5 (enExample) | ||
| JP5733551B2 (ja) | ナノコンポジット粒子およびその製造方法 | |
| ES2389471T3 (es) | Partículas coloidales biodegradables, en especial para aplicaciones pulmonares |